Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
- Patrick Schöffski*
- , Michaela Kubickova
- , Agnieszka Wozniak
- , Jean Yves Blay
- , Sandra J. Strauss
- , Silvia Stacchiotti
- , Tomasz Switaj
- , Veit Bücklein
- , Michael G. Leahy
- , Antoine Italiano
- , Nicolas Isambert
- , Maria Debiec-Rychter
- , Raf Sciot
- , Che Jui Lee
- , Frank M. Speetjens
- , Axelle Nzokirantevye
- , Anouk Neven
- , Bernd Kasper
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
66
Citations
(Scopus)